Canada Markets closed

Consolidated Research: 2018 Summary Expectations for Murphy Oil, REGENXBIO, CRA International,Inc, Carriage Services, CONMED, and BioDelivery Sciences International — Fundamental Analysis, Key Performance Indications

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Murphy Oil Corporation (MUR), REGENXBIO Inc. (RGNX), CRA International,Inc. (CRAI), Carriage Services, Inc. (CSV), CONMED Corporation (CNMD), and BioDelivery Sciences International, Inc. (BDSI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

MUR DOWNLOAD: http://MarketSourceResearch.com/register/?so=MUR
RGNX DOWNLOAD: http://MarketSourceResearch.com/register/?so=RGNX
CRAI DOWNLOAD: http://MarketSourceResearch.com/register/?so=CRAI
CSV DOWNLOAD: http://MarketSourceResearch.com/register/?so=CSV
CNMD DOWNLOAD: http://MarketSourceResearch.com/register/?so=CNMD
BDSI DOWNLOAD: http://MarketSourceResearch.com/register/?so=BDSI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Murphy Oil Corporation (MUR), REGENXBIO Inc. (RGNX), CRA International,Inc. (CRAI), Carriage Services, Inc. (CSV), CONMED Corporation (CNMD), and BioDelivery Sciences International, Inc. (BDSI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 8th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

Murphy Oil Corporation (MUR) REPORT OVERVIEW

Murphy Oil's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Murphy Oil reported revenue of $674.80MM vs $498.32MM (up 35.41%) and analysts estimated basic earnings per share $0.54 vs -$0.38. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Murphy Oil reported revenue of $2,225.13MM vs $1,811.24MM (up 22.85%) and analysts estimated basic earnings per share -$1.81 vs -$1.60. Analysts expect earnings to be released on January 30th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for the next fiscal year is $4.69 and is expected to report on January 30th, 2019.

To read the full Murphy Oil Corporation (MUR) report, download it here: http://MarketSourceResearch.com/register/?so=MUR

-----------------------------------------

REGENXBIO Inc. (RGNX) REPORT OVERVIEW

REGENXBIO's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, REGENXBIO reported revenue of $5.31MM vs $1.34MM (up 297.16%) and analysts estimated basic earnings per share -$0.56 vs -$0.67. For the twelve months ended December 31st, 2017 vs December 31st, 2016, REGENXBIO reported revenue of $10.39MM vs $4.59MM (up 126.48%) and analysts estimated basic earnings per share -$2.45 vs -$2.38. Analysts expect earnings to be released on March 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.51. The estimated EPS forecast for the next fiscal year is -$4.07 and is expected to report on March 5th, 2019.

To read the full REGENXBIO Inc. (RGNX) report, download it here: http://MarketSourceResearch.com/register/?so=RGNX

-----------------------------------------

CRA International,Inc. (CRAI) REPORT OVERVIEW

CRA International,Inc's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, CRA International,Inc reported revenue of $103.87MM vs $91.33MM (up 13.74%) and analysts estimated basic earnings per share $0.48 vs $0.39 (up 23.08%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CRA International,Inc reported revenue of $370.08MM vs $324.78MM (up 13.95%) and analysts estimated basic earnings per share $0.91 vs $1.50 (down 39.33%). Analysts expect earnings to be released on February 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.70. The estimated EPS forecast for the next fiscal year is $2.56 and is expected to report on February 21st, 2019.

To read the full CRA International,Inc. (CRAI) report, download it here: http://MarketSourceResearch.com/register/?so=CRAI

-----------------------------------------

Carriage Services, Inc. (CSV) REPORT OVERVIEW

Carriage Services' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Carriage Services reported revenue of $64.24MM vs $61.05MM (up 5.22%) and basic earnings per share $0.11 vs $0.18 (down 38.89%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Carriage Services reported revenue of $258.14MM vs $248.20MM (up 4.00%) and analysts estimated basic earnings per share $2.25 vs $1.18 (up 90.68%). Analysts expect earnings to be released on February 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.39. The estimated EPS forecast for the next fiscal year is $1.24 and is expected to report on February 13th, 2019.

To read the full Carriage Services, Inc. (CSV) report, download it here: http://MarketSourceResearch.com/register/?so=CSV

-----------------------------------------

CONMED Corporation (CNMD) REPORT OVERVIEW

CONMED's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, CONMED reported revenue of $202.31MM vs $190.12MM (up 6.41%) and analysts estimated basic earnings per share $0.21 vs $0.26 (down 19.23%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CONMED reported revenue of $796.39MM vs $763.52MM (up 4.31%) and analysts estimated basic earnings per share $1.99 vs $0.53 (up 275.47%). Analysts expect earnings to be released on January 30th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.69. The estimated EPS forecast for the next fiscal year is $2.42 and is expected to report on January 30th, 2019.

To read the full CONMED Corporation (CNMD) report, download it here: http://MarketSourceResearch.com/register/?so=CNMD

-----------------------------------------

BioDelivery Sciences International, Inc. (BDSI) REPORT OVERVIEW

BioDelivery Sciences International's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, BioDelivery Sciences International reported revenue of $12.18MM vs $8.74MM (up 39.24%) and analysts estimated basic earnings per share -$0.16 vs -$0.27. For the twelve months ended December 31st, 2017 vs December 31st, 2016, BioDelivery Sciences International reported revenue of $61.99MM vs $15.55MM (up 298.72%) and analysts estimated basic earnings per share $0.10 vs -$1.25. Analysts expect earnings to be released on March 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is -$0.38 and is expected to report on March 21st, 2019.

To read the full BioDelivery Sciences International, Inc. (BDSI) report, download it here: http://MarketSourceResearch.com/register/?so=BDSI

-----------------------------------------

ABOUT Market Source Research

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.